Skip to main content
. 2012 May 24;26(3):200–205. doi: 10.1002/jcla.21494

Table 3.

Mean Values (x¯±s) of Serum Lipid and Apolipoprotein Levels for apo E Gene in Overweight/Obese and Control Groups[Link]

Overweight/obese Controls
E2 (n = 54) E3 (n = 186) E4 (n = 42) E2 (n = 21) E3 (n = 123) E4 (n = 28)
TG (mmol/l) 2.61 ± 1.58 2.32 ± 1.56 2.22 ± 1.61 2.76 ± 3.14c,d,**,* 1.68 ± 1.12 1.80 ± 0.97
TC (mmol/l) 5.52 ± 1.01 5.74 ± 1.00 5.76 ± 1.10 5.42 ± 1.47 5.51 ± 1.12 5.67 ± 1.08
HDL‐C (mmol/l) 1.16 ± 0.26 1.21 ± 0.32 1.16 ± 0.29 1.32 ± 0.31 1.36 ± 0.30 1.29 ± 0.25
LDL‐C (mmol/l) 3.19a ± 0.73a,b,* 3.57 ± 0.93b 3.69 ± 1.11c 2.86d ± 0.74a,b,* 3.45 ± 1.07e 3.60 ± 0.97f
apo A‐I (mg/dl) 126.02 ± 23.33 128.10 ± 28.92 126.89 ± 22.48 126.74 ± 26.26 131.09 ± 23.47 128.29 ± 19.53
apo A‐II (mg/dl) 28.86 ± 5.42 28.88 ± 4.70 29.69 ± 4.55 28.79 ± 3.65 28.77 ± 4.95 29.00 ± 3.93
apo B100 (mg/dl) 88.42 ± 18.84e,* 92.13 ± 17.85 96.51 ± 19.75 81.26 ± 22.54 84.84 ± 22.28 92.39 ± 22.59
apo C‐II (mg/dl) 7.75 ± 3.09 6.79 ± 3.29 7.17 ± 3.94 7.26 ± 5.12f,* 5.37 ± 2.68 6.04 ± 3.20
apo C‐III (mg/dl) 16.50 ± 5.94 15.76 ± 6.59 16.83 ± 9.03 15.44 ± 9.59 12.71 ± 5.45 14.09 ± 6.36
apo‐E (mg/dl) 6.47 ± 2.15a,b,** 5.10 ± 1.72 5.10 ± 2.01 6.62 ± 4.72c,d, **,* 4.59 ± 1.54 4.78 ± 1.56

Subjects with TG > 4.516 mmol/l (400 mg/dl) were excluded when calculating the serum LDL‐C levels.

a,bCompared with E3 and E4 allele carriers in the same group, respectively, *P < 0.05 or **P < 0.01.

c,dCompared with E3 and E4 allele carriers in the same group, respectively, **P < 0.01, *P < 0.05.

eCompared with E4 allele carriers in the same group, *P < 0.05.

fCompared with E3 allele carriers in the same group, *P < 0.05.

Case numbers in E2, E3, and E4 are 50, 172, and 40, respectively.

Case numbers in E2, E3, and E4 are 20, 116, and 27, respectively.

gAge and sex were used as covariates in the analysis to adjust for the genotype effects.

HHS Vulnerability Disclosure